A cross-sectional retrospective study of BNT162b2 mRNA COVID-19 vaccine in patients with myasthenia gravis during the alpha, delta, and omicron waves
Latest Information Update: 14 Nov 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 01 Dec 2022 Results published in the Journal of Neurology
- 14 Nov 2022 New trial record